{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:11:15Z","timestamp":1789593075087,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.pathol.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:35:08Z","timestamp":1780641308000},"page":"742-745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unmasking aggressive NK-cell leukaemia with secondary haemophagocytic lymphohistiocytosis in a non-endemic region"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7526-4393","authenticated-orcid":false,"given":"Enrique","family":"Blanco-Pel\u00e1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2714-6731","authenticated-orcid":false,"given":"Fernando","family":"Mart\u00edn-Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Piris-Villaespesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9387-0288","authenticated-orcid":false,"given":"Beatriz","family":"Astibia-Mahillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lario-Arribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Rold\u00e1n-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Garc\u00eda-Cos\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"L\u00f3pez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2026.04.004_bib1","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2026.04.004_bib2","first-page":"1720","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia","volume":"36","author":"Alaggio","year":"2022"},{"key":"10.1016\/j.pathol.2026.04.004_bib3","article-title":"Integration of anti-PD-1 antibody into chemotherapeutic regimens improved the outcome of aggressive NK cell leukemia: a single-center retrospective real-world analysis","volume":"16","author":"Shen","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.pathol.2026.04.004_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41408-017-0021-z","article-title":"Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes","volume":"7","author":"Tang","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.pathol.2026.04.004_bib5","article-title":"Aggressive natural killer cell leukemia: a brief overview of its genomic landscape, histological features, and current management","volume":"14","author":"Sumbly","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.pathol.2026.04.004_bib6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/PAS.0000000000001518","article-title":"Genomic and immunophenotypic landscape of aggressive NK-cell leukemia","volume":"44","author":"El Hussein","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2026.04.004_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","article-title":"New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders","volume":"482","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2026.04.004_bib8","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.pathol.2026.04.004_bib9","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3390\/cancers12102900","article-title":"Aggressive NK cell leukemia: current state of the art","volume":"12","author":"El Hussein","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pathol.2026.04.004_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-016-0271-4","article-title":"L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia","volume":"9","author":"Jung","year":"2016","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.pathol.2026.04.004_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41409-020-01009-8","article-title":"Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemia","volume":"56","author":"Fujimoto","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.pathol.2026.04.004_bib12","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526005313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526005313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:57:01Z","timestamp":1789592221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302526005313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0031302526005313"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2026.04.004","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmasking aggressive NK-cell leukaemia with secondary haemophagocytic lymphohistiocytosis in a non-endemic region","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}